Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Long-term suppression of viral load and sustained CD4 cell increase reduce risk of cervical HPV infection for HIV-positive women

HIV therapy that achieves long-term suppression of viral load and sustained immune reconstitution reduces the risk of persistent cervical infection with high-risk strains of human papillomavirus (HPV), research

Published
01 April 2013
By
Michael Carter
Almost three-quarters of people starting HIV therapy in Tanzania have dyslipidemia after three years of treatment

Approximately 75% of HIV-positive patients in Tanzania had lipid abnormalities three years after starting antiretroviral therapy, research published in the online edition of Clinical Infectious Diseases shows.

Published
28 March 2013
By
Michael Carter
Study: In Malawi lifelong antiretroviral treatment for expectant moms “translates into saving more than 250,000 maternal life years”

A cost-effectiveness analysis of Option B+ in Malawi.

Published
27 March 2013
From
Science Speaks
'Test-And-Treat' Would Slow HIV Spread, Improve Health Outcomes, but Raise Drug Resistance

Wide HIV testing and early treatment woul lower HIV transmission, AIDS and death rates, but double the rate of multidrug resistance (MDR) to antiretrovirals.

Published
26 March 2013
From
AIDSMeds
Early treatment may hold key to HIV 'functional cure'

BBC News reports that one in 10 people diagnosed with HIV who receive early treatment could be 'functionally cured'. NHS Choices' Behind the Headlines analyses the reality of this report.

Published
25 March 2013
From
NHS Choices
European CHMP Adopts Positive Opinion for Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection

Gilead Sciences today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive opinion on the company’s Marketing Authorisation Application (MAA) for the once-daily, single tablet regimen Stribild® for the treatment of HIV-1 infection in adult patients who are antiretroviral-naïve or are infected with HIV-1 without known mutations associated with resistance to any of the three antiretroviral agents in Stribild. Stribild combines elvitegravir, an integrase inhibitor, and cobicistat, a pharmacoenhancing agent, with Truvada® (emtricitabine and tenofovir disoproxil (as fumarate)).

Published
22 March 2013
From
Gilead press release
EU new drug approval studies "have too few patients to evaluate safety"

For medicines intended for chronic use, the number of patients studied before regulatory approval in the European Union (EU) is insufficient to properly evaluate safety and long-term efficacy, and this points to a need for new EU legislation, say researchers writing in this week's PLOS Medicine.

Published
22 March 2013
From
Pharma Times
People doing well on HIV therapy "should be eligible" for life insurance cover

The long-term effectiveness of antiretroviral therapy means that many HIV-positive people should be eligible for affordable life insurance, European investigators write in the online edition of AIDS. Even

Published
22 March 2013
By
Michael Carter
Self-testing and home treatment initiation triples uptake of HIV treatment in Malawi

Offering people the opportunity to self-test at home and then start antiretroviral therapy after counselling at home, together with home delivery of antiretroviral drugs, increased the number

Published
21 March 2013
By
Keith Alcorn
Swiss police arrest "healer" accused of infecting 16 with HIV

Swiss police have arrested a self-styled healer after he stopped attending a trial where he stands accused of infecting 16 people with HIV using acupuncture needles.

Published
18 March 2013
From
Reuters

Filter by country